Case ReportCase Studies
Revision of Viable Environmental Monitoring in a Development Pilot Plant Based on Quality Risk Assessment: A Case Study
Ildikó Ziegler, Judit Borbély-Jakab, Lilla Sugó and Réka J. Kovács
PDA Journal of Pharmaceutical Science and Technology May 2017, 71 (3) 234-244; DOI: https://doi.org/10.5731/pdajpst.2016.007096
Ildikó Ziegler
1Validation Department, Dorog Site, Gedeon Richter Plc, Dorog, Hungary;
Judit Borbély-Jakab
2Microbiological and Hygiene Laboratory, Gedeon Richter Plc, Budapest, Hungary;
Lilla Sugó
3On leave from Quality Assurance Department, Gedeon Richter Plc, Budapest, Hungary; and
Réka J. Kovács
4Microbiological and Hygienic Laboratory, Gedeon Richter Plc, Dorog, Hungary

Reference
- 1.↵
- Mohammed-Ziegler I.,
- Medgyesi I.
- 2.↵
- Kieffer R. G.
- 3.↵U.S. Food and Drug Administration (FDA), Guidance for Industry Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice, Rockville, MD, September 2004.
- 4.↵FDA. Pharmaceutical GMPs for the 21st Century—A Risk Based Approach, Rockville, MS, September 2004.
- 5.↵European Medicines Agency (EMA). Eudralex, Volume 4, EU GMP, Annex 1. Manufacture of Sterile Medicinal Products, Section 8, Brussels, 25 November 2008.
- 6.↵International Conference on Harmonization (ICH). Q9 Quality Risk Management, Harmonised Tripartite Guideline, 2009.
- 7.↵Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S). Guide to Good Manufacturing Practice for Medicinal Products—PE 009-12 (Annexes), Annex 1. Manufacture of sterile medicinal products, Geneva, 1 October 2015.
- 8.↵World Health Organization. WHO Technical Report Series, No. 961, Annex 6. WHO Good Manufacturing Practices for Sterile Pharmaceutical Products, 2011.
- 9.↵Agencia Nacional de Vigilância Sanitária (ANVISA). Guia da Qualidade para Sistemas de Tratamento de Ar e Monitoramento Ambiental na Indústria Farmaceutica (Guide for Quality of Air-Treatment Systems and Environmental Monitoring in the Pharmaceutical Industry), Brazil, 08 May 2013.
- 10.↵EMA Concept Paper on the Revision of Annex 1 of the Guidelines on Good Manufacturing Practice—Manufacture of Sterile Medicinal Products, 2 February 2015.
- 11.↵FDA 21 Code of Federal Regulations (CFR) Part 211 Current Good Manufacturing Practice for Finished Pharmaceuticals, 01 April 2016.
- 12.↵
- Sandle T.
- 13.↵
- Lorcheim P.,
- Hughes M.
- 14.↵
- Saghee M. R.,
- Sandle T.,
- Tidswell E. C.
- Sandle T.
- 15.↵
- Sandle T.
- 16.↵
- Moldenhauer J.
- 17.↵
- Sutton S.
- 18.↵
- Akers J.,
- Agalloco J.
- 19.↵
- 20.↵
- Madigan M. T.,
- Martinko J. M.
- 21.
- Sandle T.,
- Skinner K.
- 22.↵
- O'Donnell K.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 71, Issue 3
May/June 2017
Revision of Viable Environmental Monitoring in a Development Pilot Plant Based on Quality Risk Assessment: A Case Study
Ildikó Ziegler, Judit Borbély-Jakab, Lilla Sugó, Réka J. Kovács
PDA Journal of Pharmaceutical Science and Technology May 2017, 71 (3) 234-244; DOI: 10.5731/pdajpst.2016.007096
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.
More in this TOC Section
Similar Articles